Results 111 to 120 of about 144,825 (181)

Belzutifan for patients with von Hippel-Lindau disease-associated CNS haemangioblastomas (LITESPARK-004): a multicentre, single-arm, phase 2 study. [PDF]

Lancet Oncol
Iliopoulos O, Iversen AB, Narayan V, Maughan BL, Beckermann KE, Oudard S, Else T, Maranchie JK, Goldberg CM, Fu W, Perini RF, Liu Y, Linehan WM, Srinivasan R, Jonasch E.   +14 more
europepmc   +1 more source

Accelerating Parkinson's Disease drug development with federated learning approaches. [PDF]

NPJ Parkinsons Dis
Khanna A, Adams J, Antoniades C, Bloem BR, Carroll C, Cedarbaum J, Cosman J, Dexter DT, Dockendorf MF, Edgerton J, Gaetano L, Goikoetxea E, Hill D, Horak F, Izmailova ES, Kangarloo T, Katabi D, Kopil C, Lindemann M, Mammen J, Marek K, McFarthing K, Mirelman A, Muller M, Pagano G, Peterschmitt MJ, Ren J, Rochester L, Sardar S, Siderowf A, Simuni T, Stephenson D, Swanson-Fischer C, Wagner JA, Jones GB.   +34 more
europepmc   +1 more source

Smallholder Farmer's Knowledge and Practice Towards Farm Biosecurity Measures to Prevent Infectious Diseases in Bahir Dar City, Ethiopia. [PDF]

Vet Med Sci
Mitiku BA, Gedifew AA, Ayalew TS.
europepmc   +1 more source

Selpercatinib in <i>RET</i> Fusion-Positive Non-Small Cell Lung Cancer: Final Safety and Efficacy, Including Overall Survival, From the LIBRETTO-001 Phase I/II Trial. [PDF]

J Clin Oncol
Gautschi O, Park K, Solomon BJ, Tomasini P, Loong HH, De Braud F, Goto K, Peterson P, Barker S, Liming K, Oxnard GR, Frimodt-Moller B, Drilon A.   +12 more
europepmc   +1 more source

Can digital transformation enhance labor productivity in enterprises: An analysis from the perspective of business process reengineering. [PDF]

PLoS One
Zhou Y, Lyu J, Li L.
europepmc   +1 more source

Real-World Retrospective Study of Clinical and Economic Outcomes Among Patients with Locally Advanced or Metastatic Urothelial Carcinoma Treated with First-Line Systemic Anti-Cancer Therapies in the United States: Results from the IMPACT UC-III Study. [PDF]

Curr Oncol
Moon HH, Ike C, Dixon RW, Crowe CL, Venkataraman M, Morris V, Kearney M, Tonnu-Mihara I, Barron J.   +8 more
europepmc   +1 more source

Results of a phase 1/2 study of sacituzumab tirumotecan in patients with unresectable locally advanced or metastatic solid tumors refractory to standard therapies. [PDF]

J Hematol Oncol
Ouyang Q, Rodon J, Liang Y, Wu X, Li Q, Song L, Yan M, Tong Z, Liu Y, Wainberg ZA, Wang Y, Geng C, Ulahannan SV, Yu G, Sharma MR, Wang X, Wang JS, Spira A, Zhao W, Sanborn RE, Cheng Y, Wang X, Liu G, Li Y, Ge J, Chartash E, Akala OO, Yin Y.   +27 more
europepmc   +1 more source

Artificial intelligence technology application and corporate ESG performance-evidence from national pilot zones for artificial intelligence innovation and application. [PDF]

Front Artif Intell
Xie H, Luo J, Tan X.
europepmc   +1 more source

Balancing Innovation and Equity: A Successful Dynamic Between Private and Public Sectors Is Essential to Ensure True Pandemic Influenza Preparedness. [PDF]

Vaccines (Basel)
Marsden LM, Mazur M.
europepmc   +1 more source